Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
Haroon Khan, Marya, Surriya Amin, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 101, pp. 860-870
Closed Access | Times Cited: 247

Showing 1-25 of 247 citing articles:

Neuroprotective Effects of Quercetin in Alzheimer’s Disease
Haroon Khan, Hammad Ullah, Michael Aschner, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 59-59
Open Access | Times Cited: 394
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
Thaiane Coelho dos Santos, Thaís Mota Gomes, Bruno Pinto, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 322
Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders
Muhammad Ayaz, Abdul Sadiq, Muhammad Junaid, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 291
Pyrrolizidine Alkaloids: Chemistry, Pharmacology, Toxicology and Food Safety
Rute Moreira, David M. Pereira, Patrı́cia Valentão, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1668-1668
Open Access | Times Cited: 232
Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
Rami J. Obaid, Nafeesa Naeem, Ehsan Ullah Mughal, et al.
RSC Advances (2022) Vol. 12, Iss. 31, pp. 19764-19855
Open Access | Times Cited: 85
An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge
Doha H. Abou Baker
Toxicology Reports (2022) Vol. 9, pp. 445-469
Open Access | Times Cited: 80
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Kamal Niaz, et al.
Molecules (2020) Vol. 25, Iss. 6, pp. 1267-1267
Open Access | Times Cited: 112
Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives
Salman Ahmed, Haroon Khan, Deborah Fratantonio, et al.
Phytomedicine (2019) Vol. 59, pp. 152883-152883
Closed Access | Times Cited: 100
MicroRNA targeting by quercetin in cancer treatment and chemoprotection
Doo Hwan Kim, Haroon Khan, Hammad Ullah, et al.
Pharmacological Research (2019) Vol. 147, pp. 104346-104346
Closed Access | Times Cited: 90
Cognitive impairments in type 2 diabetes, risk factors and preventive strategies
Garima Sharma, Arti Parihar, Tanay Talaiya, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 75
Physiological and UPLC-MS/MS widely targeted metabolites mechanisms of alleviation of drought stress-induced soybean growth inhibition by melatonin
Jingnan Zou, Hang Yu, Qi Yu, et al.
Industrial Crops and Products (2021) Vol. 163, pp. 113323-113323
Closed Access | Times Cited: 65
Phytochemical Profiling, In Vitro Biological Activities, and In Silico Molecular Docking Studies of Dracaena reflexa
Bilal Ahmad Ghalloo, Kashif-ur-Rehman Khan, Saeed Ahmad, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 913-913
Open Access | Times Cited: 40
Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS
Weam W. Ibrahim, Rabab H. Sayed, Mohamed F. Abdelhameed, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1091-1112
Open Access | Times Cited: 9
Phytomedicine Potential of Oroxylum indicum Root and Its Constituents: Targeting Alzheimer’s Disease
Rattana Summat, Pornthip Waiwut, Supawadee Daodee, et al.
Plants (2025) Vol. 14, Iss. 2, pp. 223-223
Open Access | Times Cited: 1
Mechanism of dsDNA binding, enzyme inhibition, antioxidant activities, and molecular docking studies of taxifolin, daidzein, and S-equol
Derya Kılıçaslan
International Journal of Biological Macromolecules (2025), pp. 140314-140314
Closed Access | Times Cited: 1
State of the art progress of Evolvulus alsinoides in pharmacological activity and plant tissue culture: A potent Chinese medicinal plant
Collince Omondi Awere, Valentine Chikaodili Anadebe, Kasinathan Rakkammal, et al.
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100586-100586
Open Access | Times Cited: 1
Anti-Inflammatory, Anti-Diabetic, and Anti-Alzheimer’s Effects of Prenylated Flavonoids from Okinawa Propolis: An Investigation by Experimental and Computational Studies
Md Shahinozzaman, Nozomi Taira, Takahiro Ishii, et al.
Molecules (2018) Vol. 23, Iss. 10, pp. 2479-2479
Open Access | Times Cited: 81
Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
Sudip Dhakal, Naufal Kushairi, Chia‐Wei Phan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5090-5090
Open Access | Times Cited: 75
Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A
Seung Cheol Baek, Mi Hyeon Park, Hyung Won Ryu, et al.
Bioorganic Chemistry (2018) Vol. 83, pp. 317-325
Closed Access | Times Cited: 68
Current standing of plant derived flavonoids as an antidepressant
Haroon Khan, Sadia Perviz, Antoni Sureda, et al.
Food and Chemical Toxicology (2018) Vol. 119, pp. 176-188
Closed Access | Times Cited: 65
High‐Throughput Label‐Free Enzymatic Assays Using Desorption Electrospray‐Ionization Mass Spectrometry
Nicolás M. Morato, Dylan T. Holden, R. Graham Cooks
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 46, pp. 20459-20464
Closed Access | Times Cited: 65
Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer’s Disease
Fahad Ali, Yasir Hasan Siddique
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 5, pp. 352-365
Closed Access | Times Cited: 63
In vitro and in vivo evaluation of enzymatic and antioxidant activity, cytotoxicity and genotoxicity of curcumin-loaded solid dispersions
Igor Silva de Sá, Ana Paula Peron, Fernanda Vitória Leimann, et al.
Food and Chemical Toxicology (2018) Vol. 125, pp. 29-37
Open Access | Times Cited: 61
Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action1
Katriona L. Hole, Robert J. Williams
Brain Plasticity (2020) Vol. 6, Iss. 2, pp. 167-192
Open Access | Times Cited: 61
Potent inhibition of acetylcholinesterase by sargachromanol I from Sargassum siliquastrum and by selected natural compounds
Jae Pil Lee, Myung-Gyun Kang, Joon Yeop Lee, et al.
Bioorganic Chemistry (2019) Vol. 89, pp. 103043-103043
Closed Access | Times Cited: 58
Page 1 - Next Page

Scroll to top